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Abstract
Background: Asymptomatic individuals are one of the major challenges for malaria elimination programs in
endemic areas. In the absence of clinical symptoms and with a lower parasite density they constitute silent
reservoirs considered important for maintaining transmission of human malaria. Studies from Brazil have shown that
infected individuals may carry these parasites for long periods.
Results: Patients were selected from three periurban endemic areas of the city of Manaus, in the western Brazilian
Amazon. Symptomatic and asymptomatic patients with positive thick blood smear and quantitative real-time PCR
(qPCR) positive for Plasmodium vivax were invited to participate in the study. A standardised pvs25 gene
amplification by qPCR was used for P. vivax gametocytes detection. Anopheles aquasalis were fed using membrane
feeding assays (MFA) containing blood from malaria patients. Parasitemia of 42 symptomatic and 25 asymptomatic
individuals was determined by microscopic examination of blood smears and qPCR. Parasitemia density and
gametocyte density were assessed as determinants of infection rates and oocysts densities. A strong correlation
between gametocyte densities (microscopy and molecular techniques) and mosquito infectivity (P < 0.001) and
oocysts median numbers (P < 0.05) was found in both groups. The ability to infect mosquitoes was higher in the
symptomatic group (41%), but infectivity in the asymptomatic group was also seen (1.42%).
Conclusions: Although their infectivity to mosquitoes is relatively low, given the high prevalence of P. vivax
asymptomatic carriers they are likely to play and important role in malaria transmission in the city of Manaus. The
role of asymptomatic infections therefore needs to be considered in future malaria elimination programs in Brazil.
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Background
Despite large reductions in burden in the least two de-
cades [1], malaria remains one of the most important
public health problems worldwide. Overall, it is esti-
mated that 3.2 billion people in 97 countries and terri-
tories are at risk of being infected with Plasmodium
species and developing the disease [1]. According to the
World Health Organization (WHO), 214 million cases
of malaria and 438,000 deaths were recorded in 2015
[1]. In Brazil, from January to November 2016, 114,287
malaria cases were recorded [2]. In the same period, the
Amazonas state and Manaus reported 44,068 [3] and
9,058 [4] malaria cases, respectively.
The naturally acquired immunity against sexual forms
of P. vivax in endemic regions remains unclear, as well
as its interference with mosquitoes infectivity or “trans-
mission-blocking effect” [5–7]. Transmission-blocking
by antibodies against Plasmodium sexual forms has been
increasingly becoming an important anti-malaria candi-
date strategy [8, 9]. Although gametocytemia has a key
role in malaria transmission, specific factors associated
with the presence, spatial and temporal patterns, and in-
fectivity of these sexual forms to mosquitoes are not well
understood. Molecular markers of gametocyte stages in-
clude pfs25/pvs25, which have been used successfully to
detect gametocytes [10–13].
The potential transmission of the malaria parasite can
be measured by Anopheles mosquitoes infection by ga-
metocytes followed by detection of oocysts and sporozo-
ites [14, 15]. Experimentally, mosquitoes can obtain a
blood meal through a membrane [15, 16] or by biting in-
fected individuals [17]. There are large discrepancies be-
tween the reported numbers of gametocytes and their
infectivity. High densities do not necessarily result in in-
fection whereas low densities can lead to infectivity [18].
Parasite infectivity is affected by vector competence
and host’s immunity and genes [19]. The infectivity of
Plasmodium gametocytes to Anopheles mosquitoes has
been shown to be modulated by several molecules such
as the antibody-like protein pfs27/25 found in the sera
of people exposed to malaria [20]. In addition to the re-
lationship between mosquito infectivity and
transmission-blocking immunity [21], complement sys-
tem activation [22] and leukocytes [23] that phagocytose
gametes inside the mosquito midgut shortly after the
mosquito takes a blood meal [19, 24], a number of stud-
ies suggest a role for immune status in the transmission
reduction of P. falciparum malaria [24, 25].
The presence of specific anti-pfs48/45 and anti-pfs230
monoclonal antibodies in the mosquito blood meal also
results in transmission reduction [26]. The combination
of all these specific hosts and vector factors, i.e. the vec-
tor immune system, the vector capacity, the relation of
the mosquito infectivity and transmission block
immunity, determine the variability and ability of game-
tocytemic individuals to infected mosquitoes.
Active detection of all parasite carriers and prompt
treatment are critical to interrupt malaria transmission
[27]. However, asymptomatic cases of malaria constitute
a major challenge for elimination programs, especially
regarding quantitation of parasitemia [28]. The use of a
cut-off parasite density limit for the classification of
asymptomatic infections and molecular tools have been
suggested [29].
A cross-sectional study carried out in 2012 in the com-
munities of Brasileirinho, Puraquequara, and Ipiranga and
also analysed in the present study, showed that the preva-
lence of asymptomatic infection was 3.67% (74/2012),
which corresponded to 85.06% (74/87) of the total P. vivax
carriers (unpublished data). A 2002 study of native
Amazonian populations showed that the prevalence of
asymptomatic infections was 14.6, 21.7, and 6.4% in the
three surveys at the same time, respectively, with a higher
prevalence of asymptomatic infections in older age groups
(odds ratio of 6.67 for people older than 40 years) [30].
Thus, the chances of presenting an asymptomatic infec-
tion increased significantly with age (Chi-square test for
trend, χ2= 10.53, P = 0.001).
The main challenge of asymptomatic malaria is the
identification of the individuals with low parasitemia
which may constitute a parasite reservoir hindering mal-
aria eradication efforts. Prevalence of asymptomatic
cases of malaria varies considerably according to popula-
tion age, previous exposure to malaria and probably also
due to parasite and host immune factors [27, 31–33].
The natural protective immunity to P. vivax and P. fal-
ciparum infection in very low transmission is not under-
stood in the context of current thinking about how
natural immunity is acquired [34]. In the absence of evi-
dence for the infectivity of these infections to mosqui-
toes, their role in and potential contribution to local
malaria transmission remains unclear. This study thus
aimed at understanding the role and impact of symp-
tomatic and asymptomatic carriers on P. vivax transmis-
sion in the endemic region of Manaus in the western
Brazilian Amazon.
Methods
Study area and patient recruitment
Here, we conducted a cross-sectional study. Symp-
tomatic patients were recruited at the Fundação de
Medicina Tropical Dr Heitor Vieira Dourado (FMT-
HVD) between April 2013 and February 2015.
Asymptomatic participants were recruited in the lo-
calities of Brasileirinho, Puraquequara, and Ipiranga,
located in the periurban area of Manaus, state of
Amazonas, Brazil (Fig. 1). Samples were collected in
these areas from June 2014 to May 2015. Each
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locality has a full-time microscopy post, where the
diagnosis of malaria is carried out. Daily, municipal
health agents visit the residents through active and
passive case detection. The clinical and parasitological
characteristics of participants determined in this study
are summarised in Table 1.
From symptomatic patients with positive thick blood
smear, 2 × 5 ml blood samples were collected by
venipuncture and stored at 37 °C until further process-
ing. One heparinised sample was used to feed mosqui-
toes and the second (EDTA) tube was used for
molecular procedures. Fifty μl of EDTA whole blood
were transferred to RNAprotect (Qiagen, Hilden,
Germany) within 1 h after sample collection. No patient
had been on anti-malarial therapy during enrollment to
the study. Data regarding age, sex, occupation, place of
Fig. 1 Hotspots of three communities of asymptomatic (red circles) and symptomatic (green star) malaria infections in the study area examined
here. Samples from symptomatic and asymptomatic individuals were collected in the city of Manaus; symptomatic patients were all from
Fundação de Medicina Tropical Dr Heitor Vieira Dourado (FMTHVD), a reference centre in tropical and infectious diseases, and the asymptomatic
cases came from three peri-urban communities of the city
Table 1 Clinical aspects, infectivity mosquitoes and prevalence of asexual and sexual stages detected by microscopy and/or
molecular biology tools in samples from symptomatic and asymptomatic malaria vivax patients
Symptomatic (n = 42) Asymptomatic (n = 25)
Male, n (%) 31 (74) 14 (56)
Age group (%)
< 25 12 24
25–34 24 28
> 34 64 48
Mean 39 34.7
Malaria previous episodes (%) 88 84
Mean of malaria episodes 4 9
Symptoms (%)
Fever 93 0
Headache 31 12
Chills 52 0
No. of dissected guts, mean ± SD (range) 27.6 ± 13.3 (11–85) 28.5 ± 13.1 (7–60)
Oocyst intensity, mean ± SD (range) 7.8 ± 18.1 (0–70) 2.1 ± 7.3 (0–35)
Parasite density by microscopy
(parasites/μl), mean ± SD (range)
Assexual forms, mean ± SD (range) 2454 ± 3148 (165–13,524) 249 ± 724 (0–3128)
Gametocytes, mean ± SD (range) 152 ± 130 (8–577) 13 ± 33 (0–151)
PCR parasite density (copies/μl)
18S rDNA, mean ± SD (range) 14,134 ± 75,180 (1446–478,640) 2446 ± 5495 (0.7–20,627)
Pvs25, mean ± SD (range) 8937 ± 31,745 (505–175,571) 2711 ± 3444 (1–10,858)
Abbreviation: SD standard deviation
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residence, and history of malaria were collected in a
questionnaire. Fever (axillary temperature ≥ 37.5 °C at
admission or history of fever in the last 48 h) and other
signs and symptoms were assessed before blood collec-
tion. Tubes and questionnaires were individually bar-
coded in the laboratory before blood collection.
Asymptomatic patients were diagnosed using 300 μl of
whole blood collected with a fingerstick lancet and
placed in a microtube containing anticoagulant (EDTA/
sodium fluoride), the final concentration was 1.8mg/ ml.
DNA was extracted from these samples using the Favor-
PrepTM 96-well Genomic DNA Kit (Favorgen, Ping-
Tung, Taiwan) and they were tested for the presence of
Plasmodium spp. infections using a validated, genus-
specific qPCR for the detection of Plasmodium spp.
(Qmal assay) ( Additional file 1: Table S1, Additional file 2:
Table S2) [35]. In case of a positive result for individuals
who accepted to take part in the study, samples of venous
blood were collected as described above. Individuals were
considered asymptomatic when they did not present symp-
toms of malaria, thirty days before and thirty days after the
blood collection to detect P. vivax.
Plasmodium vivax peripheral parasitemia and gametocyte
counts by light microscopy
Thick blood smears were Giemsa-stained and analysed
by light microscopy for malaria parasite species and per-
ipheral parasite counting by at least two independent
trained microscopists. Inconsistencies were solved by a
senior microscopist. The mean parasitemia was used.
Parasite densities (parasites/μl) were calculated by
counting the number of asexual and sexual parasites
stages per 500 leukocytes.
Assessment of P. vivax infectivity to mosquitoes
Anopheles aquasalis mosquitoes were reared under
standard laboratory conditions at 27 °C with 80% hu-
midity on a 12 h light/dark cycle. Mosquitoes were pro-
vided with 10% sucrose solution ad libitum until one
day before the infective blood meal, as described previ-
ously [36, 37].
Anopheles aquasalis were infected with P. vivax by feed-
ing blood collected from patients diagnosed with malaria
using an artificial membrane feeding system [37]. Blood
samples were maintained at 37 °C no later than one hour
until membrane feeding assays. The second group was
treated similarly but with inactivated-blood serum (IBS).
The P. vivax infective blood samples were centrifuged for
1 min at 37 °C, and the serum was removed and heated
for 1 h at 56 °C in a water bath to inactivate the comple-
ment system. In both groups, the mosquitoes were 3 to 5
days old (100 per cage for each group) and allowed to feed
for 2 h in the dark. Afterwards, engorged females were
kept with 10% sucrose daily until they were dissected on
day 7 after feeding. The midguts were dissected in a drop
of mercurochrome in phosphate-buffered saline, and
oocysts were counted by examination under 10× light
microscopy at 100× magnification (Additional file 3: Table
S3).
Molecular detection of asexual and sexual of Plasmodium
vivax
EDTA blood was stored at 37 °C until samples process-
ing. For RNA extraction, 50 μl of EDTA blood was
transferred to 250 μl of RNAprotect transferred about
30 min after sample collection. The samples were imme-
diately stored at -80 °C. A volume of 200 μl was stored
for DNA isolation. The genomic DNA was extracted
from the pelleted RBCs obtained from 200 μl blood
using FavorPrepTM 96-well Genomic DNA kit (Favor-
gen) according to the manufacturer’s instructions. RNA
from whole blood stored in RNAprotect at -80 °C was
extracted using the RNeasy® Plus 96 kit (Qiagen) as
described [35].
Both the Qmal and species-specific qPCR assays target
the 18S rRNA gene, as previously described [35, 38]. Data
were analyzed using standard curves of dilutions of the
plasmids containing the target sequences (kindly provided
by I. Felger, Swiss TPH, Basel). Cq values (cycle threshold)
of standard plasmids were used to determine the number
of copies for the genes of interests for each sample.
Analyses were performed by the software distributed by
the manufacturer (Applied Biosystems' 7500 Fast System
SDS Software, Waltham, Massachusetts, USA).
Plasmid dilutions were tested in quintuplicates. For
the detection limit, three of the five dilutions had to
be positive for P. vivax: 3 copies/μl, pvs25: 0.5 copy/μl
[35]. The efficiency of the methodology tested in the
laboratory LODs was for P. vivax: 1 copy/μl (efficiency
92.18%) and pvs25: 0.5 copy/μl (efficiency 96.20%)
(Additional file 4: Table S4).
Detection of P. vivax gametocytes by RT-qPCR to de-
tect pvs25 transcripts of this gametocyte-specific gene
was performed as previously described [35]. Plasmids
served as positive controls and as standards for the
quantification of DNA samples. Three dilutions used
were: 102, 104 and 106 copies/μl of the plasmids contain-
ing the gene fragment to be amplified. Analyses were
performed using the Applied Biosystems software 7500
Fast System SDS Software.
Statistical analysis
A person was defined as a transmitter if his/her blood sam-
ple had successfully infected at least one mosquito. A t-test
was also used to compare the median percentage of mos-
quitoes infected by parasitemia group, and the Mann-
Whitney U-test was used to compare the number of oo-
cysts per infected midgut with parasitemia group.
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Relationships between the RT-qPCR quantification of game-
tocytes, gametocytemia, oocysts per infected midgut, and
percentage of mosquitoes infected were compared using
Pearson correlation analysis. Two-sided P-values < 0.05 were
considered statistically significant. To assess whether
gametocytemia would correctly classify mosquito infec-
tion, non-parametric receiver operating characteristic
(ROC) analysis was performed. The area under the ROC
curve (AUROC) was also calculated including its confi-
dence intervals to measure the discriminative ability of
gametocytemia as a predictor of mosquito infection.
Results
Study population
Sixty-seven participants were included in the study, of
these 42 were symptomatic and 25 asymptomatic. The
mean age of symptomatic patients was 39 years, and
88% of participants reported to have had at least one
previous case of malaria (median: 3 episodes, range 1–
20). The main symptoms reported by patients were fever
(93%), chills (52%) and headache (31%). The mean para-
sitemia determined by light microscopy was 2454 para-
sites/μl (range 165–13,524) for asexual stages and 152
parasites/μl (range 8–577) for gametocytes, with the pro-
portion of 83% (35/42). By qPCR, 40/42 patients were
positive (95%) with an average 14,134 18S rRNA copies/
μl (range 1446–478,640) and 8937 pvs25 transcripts/μl
(range 505–175,571) (Table 1).
At first 35 volunteers were enrolled as asymptomatic
cases but ten of them were excluded as they showed
symptoms within 15 days after recruitment, totalling 25
individuals for statistical analysis. The mean age of
asymptomatic patients was 34.5 years with 85% of par-
ticipants reporting having had at least one case of the
disease (median: 9 episodes, range 1–43). The three
(12%) asymptomatic individuals reported headaches. The
mean parasite density as determined by light microscopy
was 249 asexual stage parasites/μl (0–3128) and 13 ga-
metocytes/μl (0–151). The average number of copies of
18S rRNA was 2446 (0.7–20,627), and 2711 (1–10,858)
for the pvs25 transcripts based on RT-qPCR analyses, in
both cases 4 μl of blood volume were used (Table 1).
Parasitemia and gametocytes detection
By optical microscopy, 83% (35/42) of the symptomatic
patients were positive for asexual and sexual stages of P.
vivax. In asymptomatic patients only 40% (10/25) of an-
alyzed samples were positive for P. vivax asexual stages
and 24% (6/25) were positive for P. vivax gametocytes
by light microscopy (Mann-Whitney U-test, U(72) = 174,
Z = 5.61, P < 0.0001 and U(72) = 152, Z = 5.94, P <
0.0001, Fig. 2a and b, respectively). The symptomatic
Fig. 2 Parasitemia distribution in the symptomatic and asymptomatic groups. Semilogarithmic plots of asexual forms (a) and gametocytes (b) as
determined by microscopy and parasite density estimated by the number of copies of 18S rRNA (c) and pvs25 (d) are shown for symptomatic
and asymptomatic blood samples. The symptomatic group showed the significantly higher density of both asexual forms (a) and gametocytes
(b) (P < 0.0001) the parasite density was observed in the number of copies of 18S rRNA (c) and pvs25 transcripts (d). The means were compared
using the Mann-Whitney test (****P < 0.0001), and the error bars represent the standard error of the mean (SEM)
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group showed significantly higher densitiy of number of
copies of 18S rRNA and pvs25 transcripts (Mann-Whit-
ney U-test, U(56) = 53, Z = 5.16, P < 0.0001 and U(64) =
158, Z = 4.61, P < 0.0001, Fig. 2c and d).
Gametocytes detected by either microscopy and RT-
qPCR showed 83% and 100% for symptomatic and 23%
and 88% for asymptomatic infections, respectively.
A strong positive association for the gametocyte-
detection techniques used (optical microscopy and pvs25
transcripts measured by RTqPCR) was observed (r2(61) =
0.529, P = 0.001, Fig. 3) highlighting a complementary
useful approach in malaria diagnosis.
Infectivity of asymptomatic patients
Asymptomatic patients had low parasitemias (Table 2),
most of them submicroscopic, yet some were able to in-
fect mosquitoes. Thirteen samples (50%) had negative
slides for P. vivax asexual forms, 18 (69%) for gameto-
cytes, and for two patients (8%), microscopy data were
not available. In the asymptomatic group, the average in-
fection rate was 1.42%, ranging from at least 0.91 to
24.24%; the average oocyst number for each sample
ranged from 1–35 oocysts.
Although the asymptomatic group with low submicro-
scopic parasitemia showed infectivity to mosquitoes, the
two groups showed significant differences in infectivity
and median oocysts by the (Mann-Whitney U-test, U(72)
= 280, Z = 4.66, P < 0.0001 and U(66) = 267.5, Z = 3.99,
P < 0.0001, Fig. 4a and b, respectively).
A strong correlation was observed between pvs25 tran-
scripts and mosquito infection rate in the symptomatic and
asymptomatic samples (r2(69) = 0.567, P < 0.001, Fig. 5a)
whereas the correlation was weaker between the median of
oocysts and gametocytes in the same groups (r2(61) = 0.286,
P < 0.05, Fig. 5b).
Furthermore, ROC analysis revealed that the geomet-
ric mean of gametocytes from symptomatic and asymp-
tomatic individuals detected by light microscopy could
be considered an acceptable classifier for mosquito in-
fection (AUROC: 0.8293, CI: 0.73–0.93) (Fig. 6). A cut-
off of 58.78 gametocytes/μl correctly classified 81.94% of
the mosquito infections (sensitivity of 82.35%, specificity
of 81.58%).
There was no significant difference in the production
of oocysts when MFAs were set up with infective sam-
ples consisting of whole blood (WB) or inactivated blood
serum (IBS) (Mann-Whitney U-test, U(40) = 219, Z =
2.019, P = 0.9748, Fig. 7). Thus, inactivation of comple-
ment factors present in blood serum did not affect me-
dian oocysts as an indicator of infectivity.
Discussion
Asymptomatic infections often go unnoticed and conse-
quently untreated, resulting in important sources of ga-
metocytes for local vectors. These infections and their
contribution transmission are poorly understood, and
there are few if any intervention that directly deals with
them.
In this study, submicroscopic gametocyte carriage was
common in an endemic malaria area in Manaus. Al-
though these patients exhibited low parasitemia, their
blood was nevertheless able to infect Anopheline mos-
quitoes. All parasitemia (asexual and sexual forms) rates
were highest in symptomatic patients. Asymptomatics
are showing a higher proportion of mature gametocytes
(pvs25 transcripts) were as effective as symptomatic in
infecting mosquitoes (Fig. 5). A recent report from
malaria-endemic regions in Colombia also showed the
prevalence of P. vivax asymptomatic submicroscopic in-
fections with mostly gametocytes as circulating parasites,
Fig. 3 Correlation between gametocytes measured by levels of pvs25 P. vivax transcripts and gametocytes visualised by microscopy. A strong
positive association between gametocyte numbers detected by RT-qPCR and those visualised by microscopy in thin blood smears from
symptomatic individuals. The values indicate the correlation coefficient (r2) (P-value < 0.001)
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Table 2 Susceptibility of An. aquasalis mosquitoes to infection with P. vivax from Brazilian asymptomatic patients
Patient
ID
Thin blood smear (parasites/μl) PCR (copies/μl) Infection
rate (%)
Oocysts
median (IQR)
Symptom-
free daysAsx Gam 18 srRNA Pvs25
1 0 0 16 nd 24.24 25 (16–34) ns
2 21 0 nd 6192 10 30 (-) ns
3 0 0 nd 2072 12.5 35 (31.5–38.5) ns
4 88 52 29 1263 0 0 7
5 0 0 51 1002 0 0 ns
6 nd nd 62 595 0 0 ns
7 nd nd nd 10,858 5.71 1 (1–1) ns
8 201 12 19 82 0 0 ns
9 3128 152 20,627 8686 14.89 12.25 (9–20) 10
10 2034 59 11,246 4393 5.12 7 (5.5–8.5) 1
11 77 0 97 240 0 0 ns
12 94 0 694 5190 0 0 14
13 0 0 186 252 0 0 30
14 0 0 1 23 0 0 4
15 0 0 1 147 1.69 1 (-) 1
16 301 40 58 262 0 0 ns
17 0 0 78 48 2.06 3.5 (2.75–4.25) ns
18 0 0 nd nd 0.91 1 (-) ns
19 0 21 nd 757 0 0 5
20 211 0 nd 8 0 0 ns
21 0 0 nd 2 0 0 7
22 65 0 nd 4 0 0 ns
23 0 0 5005 4612 0 0 ns
24 0 0 82,849 7855 0 0 ns
25 0 0 2558 7817 0 0 ns
Abbreviations: nd not determined, ns no symptoms, IQR interquartile range (25th and 75th percentile), SD standard deviation, (-) single positive mosquito
Fig. 4 Susceptibility of An. aquasalis to infection with P. vivax from Brazilian symptomatic and asymptomatic patients. Infectivity to An. aquasalis
mosquitoes (a) and oocysts (mean) at the midgut (b) are shown for symptomatic and asymptomatic blood samples used in MFAs. The means
were compared using the Mann-Whitney test (****P < 0.0001), and the error bars represent the standard error of the mean (SEM)
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of which 57% (8/14) were infective to An. albimanus
mosquitoes when blood was used in MFAs [39].
A report from the Brazilian Amazon has shown that P.
vivax can infect some mosquito species at higher rates
with increasing number of gametocytes [An. darlingi (Z =
-2.9, P < 0.01) and An. aquasalis (Z = -4.66, P < 0.001)]
[37]. A report from Peru showed an increase in the num-
ber of gametocytes about the percentage of infected mos-
quitoes (P = 0.001); the number of oocysts also increased
(P = 0.09) [19]. In a recent study with An. dirus in western
Thailand a positive correlation was also found be-
tween the infection rate and gametocyte density (P =
0.003) or pvs25 transcript abundance (P = 5 × 10-6).
The mean oocyst density generally increased with
blood parasite density (P = 2 × 10-4), gametocyte
density (P = 4 × 10-4), and pvs25 transcript abun-
dance (P = 1 × 10-8) [31]. The odds of P. vivax trans-
mission for samples with gametocytes were
significantly higher than those with no gametocytes based
on smear examination (OR: 6.35, 95% CI: 1.70–23.8,
P = 0.003) [19].
The infection rate in this study was 41% for An.
aquasalis when using blood from P. vivax symptom-
atic patients. In fact, the infection rate has been
shown to be variable depending on the study area
and Plasmodium species. In Manaus, Amazon, An.
albitarsis (s.l.), An. aquasalis, An. darlingi, An.
nuneztovari (s.l.) and An. triannulatus (s.l.), respect-
ively, showed infection rates of 44.8%, 44.7%, 18.3%,
24.5% and 8.8% [37]. In western Thailand between
2014 and 2015, 84% (59/70) of symptomatic P. vivax
blood samples were infective, i.e. at least one mos-
quito became infected with oocysts, and nearly 50%
of all 4389 An. dirus mosquitoes became infected
[31]. In Peru, the infection rate was 94% for An. dar-
lingi/P. vivax [19].
Fig. 5 Correlation between gametocytes and infection rate and oocysts median. The number of mature gametocytes (measured by pvs25
expression) is shown for MFAs performed with whole blood depending on the infection rate (a) and median of oocysts (b). The values indicate
the correlation coefficient (r2) (P < 0.001 and P < 0.05)
Fig. 6 The ROC curve demonstrated through the sensitivity and specificity of Anopheles aquasalis to P. vivax infection. ROC curve of gametocytemia of
the symptomatic and asymptomatic individuals as a predictor for mosquitoes infections; AUROC = 0.8293. The cut-off of 58.8 gametocytes/μl correctly
classified 81.49% of mosquito infections
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Anopheles darlingi and An. aquasalis are the most im-
portant malaria vectors in Brazil; previous studies have
shown differences in infection rates for these species
[35]. We observed a high production of oocysts by
symptomatic patients compared to those produced by
asymptomatic patients (Fig. 4b). An. darlingi, An. albi-
tarsis (s.l.), An. nuneztovari (s.l.) and An. triannulatus
(s.l.) field populations, and the laboratory-colonised An.
aquasalis were shown to be susceptible to P. vivax
under laboratory conditions with much higher infection
rates than those reported in nature [37]. However, some
studies have shown that mosquitoes infected in nature
have few oocysts [40]. On average carriers of gameto-
cytes at submicroscopic densities infected significantly
fewer mosquitoes that in turn led to lower oocyst
burdens [41–43].
Asymptomatic infections showing a higher gametocyte
density (transcripts/μl) were as effective as symptomatic
ones infecting mosquitoes. The ability to detect low
levels of parasitemia is crucial to identifying asymptom-
atic carriers. Microscopy detected only 10 (40%), asymp-
tomatic infections compared to the PCR-based method
that was positive for all 25 samples. This increased sensi-
tivity of molecular methods makes them suitable for
identification of asymptomatic malaria [30, 42–44].
Symptomatic patients are promptly treated and remain
infectious to mosquitoes only for a few days. Since
asymptomatic patients not recognised become the main
potentially infectious source for long periods, this can at
least partially compensate for the low infectivity rate
[43]. Thus, studying its role in transmission should be
crucial for understanding infection [44].
Individuals who have had several previous episodes of
symptomatic malaria are more likely to become asymp-
tomatic carriers upon Plasmodium infection [45]. A
higher number of previous cases of malaria were re-
ported in asymptomatic patients in this study (Table 1),
underscoring the importance of immunity in this popu-
lation. Inactivation of the blood serum before mosquito
feeding resulted in higher infection rates in An. darlingi
and An. triannulatus, but not in An. albitarsis (s.l.) and
An. aquasalis [37]. In the agreement, increased An.
aquasalis mosquito infectivity was not observed in this
study when using an inactive serum (Fig. 7). Therefore,
the immune response underlying asymptomatic infection
still needs to be elucidated.
Conclusion
This study identified the potential of asymptomatic in-
fection to contribute significantly to malaria transmis-
sion in the three communities studied in the city of
Manaus. Individuals with submicroscopic parasitemias
often do not present to health centres and become para-
site reservoirs that go unnoticed by health surveillance
and contribute to the endemicity of the disease in the
Amazon region. Therefore, more studies are needed for
this asymptomatic population to inform appropriate
strategies as part of malaria control programs.
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